Compugen
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Compugen and other ETFs, options, and stocks.About CGEN
Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses on research and development on immuno-oncology and autoimmune diseases.
CEOEran Ophir
CEOEran Ophir
Employees74
Employees74
HeadquartersHolon, Tel Aviv
HeadquartersHolon, Tel Aviv
Founded1993
Founded1993
Employees74
Employees74
CGEN Key Statistics
Market cap142.17M
Market cap142.17M
Price-Earnings ratio-5.05
Price-Earnings ratio-5.05
Dividend yield—
Dividend yield—
Average volume222.92K
Average volume222.92K
High today$1.60
High today$1.60
Low today$1.51
Low today$1.51
Open price$1.60
Open price$1.60
Volume172.45K
Volume172.45K
52 Week high$2.66
52 Week high$2.66
52 Week low$1.13
52 Week low$1.13
Stock Snapshot
The current Compugen(CGEN) stock price is $1.56, with a market capitalization of 142.17M. The stock trades at a price-to-earnings (P/E) ratio of -5.05.
As of 2025-12-07, Compugen(CGEN) stock has fluctuated between $1.51 and $1.60. The current price stands at $1.56, placing the stock +3.7% above today's low and -2.5% off the high.
Compugen(CGEN) shares are trading with a volume of 172.45K, against a daily average of 222.92K.
In the last year, Compugen(CGEN) shares hit a 52-week high of $2.66 and a 52-week low of $1.13.
In the last year, Compugen(CGEN) shares hit a 52-week high of $2.66 and a 52-week low of $1.13.
People also own
Based on the portfolios of people who own CGEN. This list is generated using Robinhood data, and it’s not a recommendation.